Our reporters bring you news and highlights from BIO’s in-person and virtual events.
Scientists fear the next pandemic could come from antimicrobial resistance, which already causes 2.8 million infections and more than 35,000 deaths in the United …
Panel decries lack of attention for antimicrobial resistance Read More »
If new restrictions are placed on the FDA’s Accelerated Approval pathway, a program to speed market access for drugs addressing serious conditions, as many …
Report shows Accelerated Approval’s value in money and lives Read More »
Remarks from Paul Hastings, CEO of Nkarta Therapeutics and Chairman of the Biotechnology Innovation Organization (BIO), as prepared for delivery at the BIO International …
Venus Williams has won seven Grand Slam singles titles, five at Wimbledon and two at the US Open. She’s also won four Olympic gold …
Venus Williams on tennis, health advocacy, and having ‘no limits’ Read More »
On Day 3, the Good Day BIO Team brings you exclusive interviews with BIO’s Phyllis Arthur, Novavax’s John Trizzino, and BioGENEius winner Okezue Bell, …
Good Day BIO LIVE! from San Diego – watch Wednesday’s episode Read More »
Life sciences and the biotechnology industry are key to the economic health of the world, America, and individual states. Helping biotech grow requires new …
State officials explain how—and why—they build their biotech sector Read More »
The South Carolina Biotechnology Industry Organization (SCBIO) is pleased to announce the launch of its first-in-kind, next-generation life sciences workforce development mobile app, undertaken …
SCBIO launches ‘Rad Lab’: South Carolina’s Life Sciences Workforce Game-Changing App Read More »
FDA’s greater reliance on digital tools during the pandemic showed the agency how these tools could be used to expand the size and diversity …
FDA officials see benefits of pandemic-driven digitalization Read More »
The market is volatile, to say the least – but it’s not entirely bad for biotechs, especially those with innovative science, said McKinsey & …
The FDA’s Accelerated Approval Pathway must be preserved against current threats as it has been a lifeline for patients with rare diseases, life-threatening conditions, …
FDA Accelerated Approval Pathway must be preserved, experts say Read More »
